VICTORY CAPITAL MANAGEMENT INC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 134 filers reported holding IMMUNITYBIO INC in Q3 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$23,709
-46.1%
14,029
+19.5%
0.00%
Q2 2022$44,000
+2.3%
11,741
-0.6%
0.00%
Q1 2022$43,000
-38.6%
11,816
+2.1%
0.00%
Q4 2021$70,000
-71.8%
11,568
-54.6%
0.00%
Q3 2021$248,000
-28.9%
25,458
+4.2%
0.00%
Q2 2021$349,000
-58.7%
24,425
-31.5%
0.00%
-100.0%
Q1 2021$846,00035,6530.00%
Other shareholders
IMMUNITYBIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders